The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Blueprint Medicines
Stock and Other Ownership Interests - Blueprint Medicines
Clinical activity of the RET inhibitor pralsetinib (BLU-667) in patients with RET fusion+ solid tumors.
 
Vivek Subbiah
Consulting or Advisory Role - Helsinn Therapeutics; Loxo; MedImmune; QED Therapeutics; R-Pharm
Research Funding - Abbvie (Inst); Agensys (Inst); Alfasigma (Inst); Amgen (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); Blueprint Medicines (Inst); Boston Biomedical (Inst); D3 Oncology Solutions (Inst); Exelixis (Inst); Fujifilm (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Idera (Inst); Incyte (Inst); Inhibrx (Inst); LOXO (Inst); Multivir (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Takeda (Inst); Turning Point Therapeutics (Inst); Vegenics (Inst)
Travel, Accommodations, Expenses - Bayer; Helsinn Therapeutics; Novartis; PharmaMar
Other Relationship - Medscape
 
Mimi I-Nan Hu
Consulting or Advisory Role - Blueprint Medicines; Lilly; Loxo
Research Funding - Lilly; Sanofi
 
Justin F. Gainor
Employment - Ironwood Pharmaceuticals (I)
Stock and Other Ownership Interests - Ironwood Pharmaceuticals (I)
Honoraria - ARIAD; Incyte; Merck; Novartis; Pfizer; Takeda
Consulting or Advisory Role - Agios; Amgen; Array BioPharma; Blueprint Medicines; Bristol-Myers Squibb; Genentech; Gilead Sciences; Jounce Therapeutics; Lilly; Loxo; Merck; Moderna Therapeutics; Oncorus; Regeneron; Takeda; Theravance
Research Funding - Adaptimmune (Inst); Alexo Therapeutics (Inst); ARIAD; Array BioPharma (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Genentech; Jounce Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Novartis (Inst); Tesaro (Inst)
 
Aaron Scott Mansfield
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Abbvie; Roche
 
Guzman Alonso
No Relationships to Disclose
 
Matthew H. Taylor
Consulting or Advisory Role - ArQule; Array BioPharma; Bayer; Blueprint Medicines; Bristol-Myers Squibb; Eisai; Loxo; Novartis; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Eisai; Merck
 
Viola Weijia Zhu
Stock and Other Ownership Interests - TP Therapeutics; TP Therapeutics (I)
Honoraria - AstraZeneca; Roche/Foundation Medicine; Roche/Genentech; Takeda
Consulting or Advisory Role - AstraZeneca; Takeda; TP Therapeutics
Speakers' Bureau - AstraZeneca; Roche/Foundation Medicine; Roche/Genentech; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Roche/Foundation Medicine; Roche/Genentech; Takeda; TP Therapeutics
 
Pilar Garrido Lopez
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Guardant Health; Janssen-Cilag; Lilly; MSD Oncology; Pfizer; Roche Pharma AG; Takeda
Speakers' Bureau - AstraZeneca; Gilead Sciences; MSD Oncology; Roche Pharma AG; Takeda
Research Funding - Guardant Health (Inst); Sysmex (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Alessio Amatu
Consulting or Advisory Role - Amgen; Bayer; Roche
 
Robert C Doebele
Stock and Other Ownership Interests - Rain Therapeutics
Consulting or Advisory Role - Anchiano; AstraZeneca; Bayer; Blueprint Medicines; Genentech/Roche; GreenPeptide; Rain Therapeutics; Takeda
Patents, Royalties, Other Intellectual Property - Abbott Molecular; Rain Therapeutics
Travel, Accommodations, Expenses - Blueprint Medicines; Genentech/Roche; GreenPeptide; Rain Therapeutics; Takeda
 
Philippe Alexandre Cassier
Honoraria - Amgen; AstraZeneca; Blueprint Medicines; Novartis; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Innate Pharma (Inst); Janssen (Inst); Lilly (Inst); Loxo (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Plexxikon (Inst); Roche/Genentech (Inst); Taiho Pharmaceutical (Inst); Toray Industries (Inst); Transgene (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Netris Pharma; Novartis; Roche
 
Bhumsuk Keam
Consulting or Advisory Role - ABL Bio; AstraZeneca; Cellid; Genexine; MSD Oncology
Research Funding - AstraZeneca; MSD Oncology; Ono Pharmaceutical
 
Martin H. Schuler
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MorphoSys; Novartis; Roche; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Highly sensitive method for mutation detection by PCR (Inst)
 
Hui Zhang
Employment - Blueprint Medicines
Stock and Other Ownership Interests - Blueprint Medicines
 
Corinne Clifford
Employment - Blueprint Medicines
Stock and Other Ownership Interests - Blueprint Medicines
 
Michael Palmer
No Relationships to Disclose
 
Jennifer Green
Employment - Celldex
Stock and Other Ownership Interests - Celldex
Consulting or Advisory Role - Blueprint Medicines
 
Christopher D. Turner
Employment - Blueprint Medicines; Celldex
Stock and Other Ownership Interests - Blueprint Medicines; Celldex
 
Giuseppe Curigliano
Honoraria - Ellipses Pharma
Consulting or Advisory Role - Bristol-Myers Squibb; Foundation Medicine; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung
Speakers' Bureau - Daiichi Sankyo; Foundation Medicine; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung
Travel, Accommodations, Expenses - Pfizer; Roche/Genentech